Using Synthetically Engineered Guide RNAs to Enhance CRISPR Genome Editing Systems in Mammalian Cells

CRISPR-Cas9 is quickly revolutionizing the way we approach gene therapy. CRISPR-Cas9 is a complexed, two-component system using a short guide RNA (gRNA) sequence to direct the Cas9 endonuclease to the target site. Modifying the gRNA independent of the Cas9 protein confers ease and flexibility to imp...

Full description

Bibliographic Details
Main Authors: Daniel Allen, Michael Rosenberg, Ayal Hendel
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Genome Editing
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgeed.2020.617910/full
_version_ 1818339205851381760
author Daniel Allen
Michael Rosenberg
Ayal Hendel
author_facet Daniel Allen
Michael Rosenberg
Ayal Hendel
author_sort Daniel Allen
collection DOAJ
description CRISPR-Cas9 is quickly revolutionizing the way we approach gene therapy. CRISPR-Cas9 is a complexed, two-component system using a short guide RNA (gRNA) sequence to direct the Cas9 endonuclease to the target site. Modifying the gRNA independent of the Cas9 protein confers ease and flexibility to improve the CRISPR-Cas9 system as a genome-editing tool. gRNAs have been engineered to improve the CRISPR system's overall stability, specificity, safety, and versatility. gRNAs have been modified to increase their stability to guard against nuclease degradation, thereby enhancing their efficiency. Additionally, guide specificity has been improved by limiting off-target editing. Synthetic gRNA has been shown to ameliorate inflammatory signaling caused by the CRISPR system, thereby limiting immunogenicity and toxicity in edited mammalian cells. Furthermore, through conjugation with exogenous donor DNA, engineered gRNAs have been shown to improve homology-directed repair (HDR) efficiency by ensuring donor proximity to the edited site. Lastly, synthetic gRNAs attached to fluorescent labels have been developed to enable highly specific nuclear staining and imaging, enabling mechanistic studies of chromosomal dynamics and genomic mapping. Continued work on chemical modification and optimization of synthetic gRNAs will undoubtedly lead to clinical and therapeutic benefits and, ultimately, routinely performed CRISPR-based therapies.
first_indexed 2024-12-13T15:23:19Z
format Article
id doaj.art-153c5e30a01f41efb8e97ce6ac159ebb
institution Directory Open Access Journal
issn 2673-3439
language English
last_indexed 2024-12-13T15:23:19Z
publishDate 2021-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genome Editing
spelling doaj.art-153c5e30a01f41efb8e97ce6ac159ebb2022-12-21T23:40:28ZengFrontiers Media S.A.Frontiers in Genome Editing2673-34392021-01-01210.3389/fgeed.2020.617910617910Using Synthetically Engineered Guide RNAs to Enhance CRISPR Genome Editing Systems in Mammalian CellsDaniel AllenMichael RosenbergAyal HendelCRISPR-Cas9 is quickly revolutionizing the way we approach gene therapy. CRISPR-Cas9 is a complexed, two-component system using a short guide RNA (gRNA) sequence to direct the Cas9 endonuclease to the target site. Modifying the gRNA independent of the Cas9 protein confers ease and flexibility to improve the CRISPR-Cas9 system as a genome-editing tool. gRNAs have been engineered to improve the CRISPR system's overall stability, specificity, safety, and versatility. gRNAs have been modified to increase their stability to guard against nuclease degradation, thereby enhancing their efficiency. Additionally, guide specificity has been improved by limiting off-target editing. Synthetic gRNA has been shown to ameliorate inflammatory signaling caused by the CRISPR system, thereby limiting immunogenicity and toxicity in edited mammalian cells. Furthermore, through conjugation with exogenous donor DNA, engineered gRNAs have been shown to improve homology-directed repair (HDR) efficiency by ensuring donor proximity to the edited site. Lastly, synthetic gRNAs attached to fluorescent labels have been developed to enable highly specific nuclear staining and imaging, enabling mechanistic studies of chromosomal dynamics and genomic mapping. Continued work on chemical modification and optimization of synthetic gRNAs will undoubtedly lead to clinical and therapeutic benefits and, ultimately, routinely performed CRISPR-based therapies.https://www.frontiersin.org/articles/10.3389/fgeed.2020.617910/fullCRISPR-Cas9engineered nucleasegRNAchemical modificationsgenome editinggene therapy
spellingShingle Daniel Allen
Michael Rosenberg
Ayal Hendel
Using Synthetically Engineered Guide RNAs to Enhance CRISPR Genome Editing Systems in Mammalian Cells
Frontiers in Genome Editing
CRISPR-Cas9
engineered nuclease
gRNA
chemical modifications
genome editing
gene therapy
title Using Synthetically Engineered Guide RNAs to Enhance CRISPR Genome Editing Systems in Mammalian Cells
title_full Using Synthetically Engineered Guide RNAs to Enhance CRISPR Genome Editing Systems in Mammalian Cells
title_fullStr Using Synthetically Engineered Guide RNAs to Enhance CRISPR Genome Editing Systems in Mammalian Cells
title_full_unstemmed Using Synthetically Engineered Guide RNAs to Enhance CRISPR Genome Editing Systems in Mammalian Cells
title_short Using Synthetically Engineered Guide RNAs to Enhance CRISPR Genome Editing Systems in Mammalian Cells
title_sort using synthetically engineered guide rnas to enhance crispr genome editing systems in mammalian cells
topic CRISPR-Cas9
engineered nuclease
gRNA
chemical modifications
genome editing
gene therapy
url https://www.frontiersin.org/articles/10.3389/fgeed.2020.617910/full
work_keys_str_mv AT danielallen usingsyntheticallyengineeredguidernastoenhancecrisprgenomeeditingsystemsinmammaliancells
AT michaelrosenberg usingsyntheticallyengineeredguidernastoenhancecrisprgenomeeditingsystemsinmammaliancells
AT ayalhendel usingsyntheticallyengineeredguidernastoenhancecrisprgenomeeditingsystemsinmammaliancells